Cite
HARVARD Citation
Kim, M. et al. (n.d.). Efficacy of the MDM2 inhibitor SAR405838 in PDX models of GBM is limited by active efflux at the BBB. European journal of cancer. pp. S67-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, M. et al. (n.d.). Efficacy of the MDM2 inhibitor SAR405838 in PDX models of GBM is limited by active efflux at the BBB. European journal of cancer. pp. S67-. [Online].